EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Responses to GLP ‐ 1RA in White and Black Adults With Obesity: Insights From Generalized Additive Mixed Models of EHR Data

Jordan H Mallette, Joshua S Speed, Seth T Lirette iD, Daniel Moore, John S Clemmer

Obesity · 2026

DOI: 10.1002/oby.70180 ↗

At a glance

Journal article in Obesity, 2026. Written by Jordan H Mallette and 4 co-authors. Institution: Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi, USA. Major MEDLINE topics: Black or African American, Glucagon-Like Peptide-1 Receptor Agonists, Obesity. 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIDDK NIH HHS, NHLBI NIH HHS, NIGMS NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

This study examined racial differences in weight loss and clinical response to glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) therapy among adults with obesity using real‐world data.

Methods

We retrospectively analyzed our institution's Research Data Warehouse (RDW) containing deidentified data from electronic health records (EHRs) from adults aged 18 years and older. EHR data from the University of Mississippi Medical Center RDW were analyzed for 7214 adults (2182 White; 5032 Black) prescribed injectable GLP‐1RA between 2015 and 2025. Inclusion criteria were BMI ≥ 30 kg/m 2 and ≥ 1 GLP‐1RA. Longitudinal changes in patient data were modeled using generalized additive mixed models.

Results

At 2.5 years, White individuals experienced significantly greater body weight loss than Black individuals: −7.1% (95% CI −8.0%, −6.2%) versus −4.9% (95% CI −5.4%, −4.3%), as well as significantly larger reductions in estimated glomerular filtration rate, systolic blood pressure, and HbA1c. Semaglutide and tirzepatide were associated with the greatest improvements. Renal function decline was attenuated in both groups after therapy.

Conclusions

In a large, diverse EHR cohort, GLP‐1RA therapy was associated with significant weight, glycemic, and renal benefits that were attenuated in Black adults. These findings highlight the urgent need to understand mechanisms contributing to variable GLP‐1RA outcomes among different populations.

Subjects

MeSH terms (MEDLINE)

Black or African AmericanGlucagon-Like Peptide-1 Receptor AgonistsObesityAdultFemaleHumansMaleMiddle AgedElectronic Health RecordsGlomerular Filtration RateGlycated HemoglobinHypoglycemic AgentsRetrospective StudiesSemaglutideTirzepatideWeight LossWhite

Author keywords

GLP‐1 agonistobesityracial disparitiesweight loss

Substances

Glucagon-Like Peptide-1 Receptor AgonistsGlycated HemoglobinHypoglycemic AgentsSemaglutideTirzepatide

Authors and institutions

  • Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi, USA.
  • Department of Data Science, University of Mississippi Medical Center, Jackson, Mississippi, USA.

ORCID profiles: Seth T Lirette

Funding

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • NIMHD NIH HHS
  • National Institute on Minority Health and Health Disparities
  • National Institute of General Medical Sciences
  • National Heart, Lung, and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases

Cite

APA

Mallette, J. H., Speed, J. S., Lirette, S. T., Moore, D., & Clemmer, J. S. (2026). Responses to GLP ‐ 1RA in White and Black Adults With Obesity: Insights From Generalized Additive Mixed Models of EHR Data. Obesity. https://doi.org/10.1002/oby.70180

Vancouver

Mallette JH, Speed JS, Lirette ST, Moore D, Clemmer JS. Responses to GLP ‐ 1RA in White and Black Adults With Obesity: Insights From Generalized Additive Mixed Models of EHR Data. Obesity. 2026. doi:10.1002/oby.70180

BibTeX
@article{Mallette2026,
  author = {Mallette, Jordan H and Speed, Joshua S and Lirette, Seth T and Moore, Daniel and Clemmer, John S},
  title = {Responses to GLP ‐ 1RA in White and Black Adults With Obesity: Insights From Generalized Additive Mixed Models of EHR Data},
  journal = {Obesity},
  year = {2026},
  doi = {10.1002/oby.70180}
}
Start for free →